BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 31321907)

  • 21. Detection and monitoring of a concomitant atypical myeloproliferative disorder and chronic lymphocytic leukemia by flow-cytometric immunophenotyping.
    McCoy JP; Johnson E; Catalano E; Blumstein L; Overton WR; Gryn J; Donaldson MH
    Arch Pathol Lab Med; 1995 Nov; 119(11):1038-43. PubMed ID: 7487404
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Flow cytometry: an overview.
    Villas BH
    Cell Vis; 1998; 5(1):56-61. PubMed ID: 9660728
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Types of blood cancers--and new molecular diagnostics.
    Dash DP; Janasik M
    MLO Med Lab Obs; 2013 Aug; 45(8):8, 10, 12. PubMed ID: 24205533
    [No Abstract]   [Full Text] [Related]  

  • 24. A java-based application for differential diagnosis of hematopoietic neoplasms using immunophenotyping by flow cytometry.
    Nguyen AN; Milam JD; Johnson KA; Banez EI
    Comput Biol Med; 2000 Jul; 30(4):225-35. PubMed ID: 10821940
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Loss of blast heterogeneity in myelodysplastic syndrome and other chronic myeloid neoplasms.
    Jevremovic D; Timm MM; Reichard KK; Morice WG; Hanson CA; Viswanatha DS; Howard MT; Nguyen PL
    Am J Clin Pathol; 2014 Sep; 142(3):292-8. PubMed ID: 25125617
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preface.
    Verstovsek S
    Best Pract Res Clin Haematol; 2014 Jun; 27(2):81-2. PubMed ID: 25189719
    [No Abstract]   [Full Text] [Related]  

  • 27. Clinical applications of molecular haematology: an overview.
    Bain BJ
    J Assoc Physicians India; 2007 Jul; 55():503-6. PubMed ID: 17907501
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Harmonemia: a universal strategy for flow cytometry immunophenotyping-A European LeukemiaNet WP10 study.
    Lacombe F; Bernal E; Bloxham D; Couzens S; Porta MG; Johansson U; Kern W; Macey M; Matthes T; Morilla R; Paiva A; Palacio C; Preijers F; Ratei R; Siitonen S; Allou K; Porwit A; Béné MC
    Leukemia; 2016 Aug; 30(8):1769-72. PubMed ID: 26922887
    [No Abstract]   [Full Text] [Related]  

  • 29. The Interpretation of Sequence Variants in Myeloid Neoplasms.
    Hanbazazh M; Harada S; Reddy V; Mackinnon AC; Harbi D; Morlote D
    Am J Clin Pathol; 2021 Oct; 156(5):728-748. PubMed ID: 34155503
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel multi-parameter flow cytometry sensitively detects phenotypically distinct plasma cell subsets in plasma cell proliferative disorders.
    Morice WG; Hanson CA; Kumar S; Frederick LA; Lesnick CE; Greipp PR
    Leukemia; 2007 Sep; 21(9):2043-6. PubMed ID: 17460704
    [No Abstract]   [Full Text] [Related]  

  • 31. Multidimensional flow cytometry immunophenotyping of hematologic malignancy.
    Pagnucco G; Vanelli L; Gervasi F
    Ann N Y Acad Sci; 2002 Jun; 963():313-21. PubMed ID: 12095957
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 2006 Bethesda International Consensus Conference on Flow Cytometric Immunophenotyping of Hematolymphoid Neoplasia.
    Stetler-Stevenson M; Davis B; Wood B; Braylan R
    Cytometry B Clin Cytom; 2007; 72 Suppl 1():S3. PubMed ID: 17630651
    [No Abstract]   [Full Text] [Related]  

  • 33. Gene expression profiling: will it complement or replace immunophenotyping?
    Ferrando AA; Thomas Look A
    Best Pract Res Clin Haematol; 2003 Dec; 16(4):645-52. PubMed ID: 14592648
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Atypical myeloproliferative disorders in adults.
    Zachée P
    Transfus Apher Sci; 2011 Apr; 44(2):211-21. PubMed ID: 21402312
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Panel proposal for the immunophenotypic diagnosis of hematological malignancies. A collaborative consensus from the groupe d'Etude Immunologique des Leucémies (GEIL).
    Collective Publication
    Cytometry B Clin Cytom; 2018 May; 94(3):542-547. PubMed ID: 29160946
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Principles of minimal residual disease detection for hematopoietic neoplasms by flow cytometry.
    Wood BL
    Cytometry B Clin Cytom; 2016 Jan; 90(1):47-53. PubMed ID: 25906832
    [TBL] [Abstract][Full Text] [Related]  

  • 37. One tube with eight antibodies for 14-part bone marrow leukocyte differential using flow cytometry.
    Jacob MC; Souvignet A; Pont J; Solly F; Mondet J; Kesr S; Pernollet M; Dumestre-Perard C; Campos L; Cesbron JY
    Cytometry B Clin Cytom; 2017 Jul; 92(4):299-309. PubMed ID: 26990701
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A web-based database for diagnosis of haematologic neoplasms using immunophenotyping by flow cytometry.
    Nguyen A; Wu S; Jalali M; Uthman M; Johnson K; Banez E
    Med Inform Internet Med; 2001; 26(4):309-23. PubMed ID: 11783714
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnosis, staging and prognostic factors.
    Schouten HC
    Ann Oncol; 2007 Jan; 18 Suppl 1():i22-i28. PubMed ID: 17311817
    [No Abstract]   [Full Text] [Related]  

  • 40. Interpreting flow cytometry for hematologic neoplasms.
    Dayton V; Nguyen PL; Jaszcz V
    Am J Clin Pathol; 2000 Jul; 114(1):151-3. PubMed ID: 10884812
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.